• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Coral

    Delhi HC Directs CDSCO on Zydus Semaglutide Safety Concerns

    ECONOMICTIMES

    Semaglutide Linked to Better Quality of Life in CKD: FLOW Trial

    PR NEWSWIRE

    Biomea Partners with Leicester to Study Icovamenib in Obesity

    GLOBENEWSWIRE

    Wegovy Pill Launches in UAE as Novo Expands Obesity Access

    GLOBENEWSWIRE

    Alkem Launches Semaglutide Pre-Filled Syringes in India

    EXPRESSPHARMA

    Alkem Launches Single-Shot Semaglutide Syringe at Rs. 350

    INDPHARMAPOST

    Mapi Pharma Joins ASCO Annual Meeting And ADA 2026 Sessions

    GLOBENEWSWIRE

    Felix Offers Ozempic at Generic-Level Pricing in Canada

    GLOBENEWSWIRE

    Lilly to Present Foundayo, Mounjaro Data at ADA 2026

    PR NEWSWIRE

    Ondra Health Launches Nationwide GLP-1 Weight Loss Platform

    BUSINESSWIRE

    Ozari Health Releases New Industry Research on GLP-1 Pricing

    GLOBENEWSWIRE

    Brazil Approves First Generic Version of Ozempic

    REUTERS

    Navigating Legal and Regulatory Landscape of GLP-1 Drugs in India

    EXPRESSPHARMA

    CHMP Backs Oral Semaglutide as Most Efficacious GLP-1 Pill

    GLOBENEWSWIRE

    CHMP Backs Wegovy 7.2 mg for Up to 20.7% Weight Loss

    GLOBENEWSWIRE

    Hims & Hers Launches Generic Semaglutide in Canada

    BUSINESSWIRE

    MedExpress Canada Launches Generic Semaglutide At $124.99

    FIRSTWORD PHARMA

    Shaily Launches Combo Product with ShailyPen Neo Technology

    EXPRESSPHARMA

    OTC Phentermine Alternatives 2026: PhenQ Assessed via SCALE-9

    GLOBENEWSWIRE

    Phoenix, Raven 1st Canada Telehealth to Offer Generic Semaglutide

    BUSINESSWIRE

    FDA Issues Warning Letter Over Chinese Supplier`s GLP-1 Import

    BIOSPACE

    Dr Reddy`s launches oral semaglutide biosimilar Obeda in India

    ECONOMICTIMES

    Ozari Health Launches Telehealth for Semaglutide from $86/Month

    GLOBENEWSWIRE

    BioNxt Advances Semaglutide ODF into Active Pharma Development

    PHARMIWEB

    Novo Nordisk to Unveil Semaglutide Data on Liver Disease

    GLOBENEWSWIRE

    Caliway: CBL-514 Preclinical Data Presented at ECO 2026

    PR NEWSWIRE

    India’s Counterfeit Drug Crisis & Role of AI

    EXPRESSPHARMA

    Apotex Launches Generic Semaglutide Injection in Canada

    PRESS RELEASE

    Semaglutide Price Drop Expected Amid Generic Expansion In India

    ECONOMICTIMES

    Veru Unveils Q2 2026 Financials, Advances PLATEAU Trial Phase 2B

    GLOBENEWSWIRE

    Novo Nordisk Data Shows Wegovy Pill Achieves 21.6% Weight Loss

    GLOBENEWSWIRE

    Generic Entry Sparks GLP-1 Boom in India

    PHARMABIZ

    Novo Nordisk: Wegovy Shows 28% Weight Loss in Early Responders

    GLOBENEWSWIRE

    Lilly`s Foundayo & Low-Dose Zepbound Help Maintain Weight Loss

    PR NEWSWIRE

    Semaglutide Race: Torrent Grabs 38% Market Share

    ECONOMICTIMES

    Novi GLP-1 Weight Loss Options Evaluated With Dedicated Doctors

    GLOBENEWSWIRE

    Medicare Expands Wegovy Access for Obesity From July 2026

    PR NEWSWIRE

    Amazon Adds Ozempic Pill To Same-Day Prescription Drug Kiosks

    ENDPOINTS

    Hepta Reveals Blood-Based Epigenetic Signatures of GLP-1 Response

    PHARMIWEB

    Onesource Supports Second Generic Semaglutide Approval In Canada

    EXPRESSPHARMA

    OneSource Partners Win Health Canada Nod for Generic Semaglutide

    INDPHARMAPOST

    Ozempic Maker To Pilot Diabetes, Obesity Treatments In Singapore

    FIRSTWORD PHARMA

    Affordable Semaglutide & Tirzepatide GLP-1 Program Assessed

    GLOBENEWSWIRE

    Novo Nordisk Launches Ozempic Oral Pill For Type 2 Diabetes

    PR NEWSWIRE

    Weight Watchers Expands Med+ With New Ozempic (Semaglutide)

    GLOBENEWSWIRE

    Goodrx Adds Ozempic Pill For Type 2 Diabetes Patients

    PHARMIWEB

    Apotex First Canadian Pharma Co. To Get Health Canada Approval

    PR NEWSWIRE

    U.S. Prescription Drug Spending Poised To Cross $1 Trillion

    PR NEWSWIRE

    FDA Proposes Excluding Semaglutide, Tirzepatide, Liraglutide

    FDA

    Weight-Loss Drugs May Also Help Cut Alcohol Intake: Study

    ECONOMICTIMES

    Dr. Reddy`s Wins Health Canada Nod for Generic Semaglutide

    BUSINESSWIRE

    Onesource Pharma, Dr Reddy`s Secure Health Canada Nod

    INDPHARMAPOST

    Dr Reddy`s Laboratories Receives Approval From Health Canada

    PRESS RELEASE

    Novo Nordisk at ECO: Wegovy & Next-Gen Weight Loss Treatments

    GLOBENEWSWIRE

    Novo Eyes Adolescent Diabetes Approval for Oral Semaglutide

    FIERCE PHARMA

    MHRA Approves 48-Hour Controlled-Temp Storage for Wegovy

    PHARMIWEB

    Experts Scrutinize SkinnyRx`s GLP-1 Semaglutide Claims

    GLOBENEWSWIRE

    Enforcement Report - Week of April 22, 2026

    FDA

    FDA issues warning letter after GLP-1 manufacturer

    FDA

    Onesource And Orbicular Secure USFDA Tentative Approval

    EXPRESSPHARMA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.